NCT01110928View on ClinicalTrials.gov

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

CompletedOBSERVATIONAL
Enrollment

227

Participants

Timeline

Start Date

November 26, 2009

Primary Completion Date

November 12, 2018

Study Completion Date

November 12, 2018

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

Norditropin® (somatropin) prescribed at the discretion of the physician according to normal clinical practice. Safety and effectiveness data is recorded by the physician, at study initiation and every 6 months until last visit.

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY